Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Isocitrate dehydrogenase type I mutation as a prognostic factor in glioblastoma and a literature review].

Neurocirugia (Asturias, Spain) - 1 Jan 2000

de Quintana-Schmidt Cristian, Alvarez-Holzapfel María Jesús, Nomdedeu-Guinot Josep, Bague-Rosell Silvia, Gallego-Rubio Oscar, Leidinger Andreas, Salgado-Lopez Laura, Molet-Teixidó Joan

Abstract excerpt

OBJECTIVE: Treatment response and prognosis in glioblastoma (GBM) tumours can differ among patients, highlighting the growing relevance of genetic biomarkers to differentiate glioblastoma sub-types. The biomarker isocitrate dehydrogenase (IDH1) is currently receiving considerable attention. The objective of this work was to analyse the clinical and prognostic differences between glioblastomas with and without the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Brain Neoplasms

Share to Glioblastoma

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Prognosis

Share to Young Adult

Source

Identifiers

PMID: 26194445
DOI: 10.1016/j.neucir.2015.04.001

Genes

IDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Isocitrate dehydrogenase type I mutation as a prognostic factor in glioblastoma and a literature review].PMID 26194445Read ↗

Prognostic significance of IDH 1 mutation in patients with glioblastoma multiforme.Semantic proximity Read ↗

[Clinical, immunohistochemical, and molecular genetic prognostic factors in adult patients with glioblastoma].Semantic proximity Read ↗

Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas.Semantic proximity Read ↗

Assessment of the Association between Isocitrate Dehydrogenase 1 Mutation and Mortality Risk of Glioblastoma Patients.Semantic proximity Read ↗

Genetics and Epigenetics of Glioblastoma: Applications and Overall Incidence of IDH1 MutationSemantic proximity Read ↗

IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis.Semantic proximity Read ↗

Isocitrate dehydrogenase mutations in defining the biology of and supporting clinical decision making in glioblastoma.Semantic proximity Read ↗

Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a review.Semantic proximity Read ↗

IDH1/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis.Semantic proximity Read ↗

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.Semantic proximity Read ↗

[Analysis of clinical, pathological features and therapeutic treatments in predicting prognosis of elderly glioblastomas].Semantic proximity Read ↗

Clinical Impact of IDH1 Mutations and MGMT Methylation in Adult GlioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.